Lugano, Switzerland – ESMO GI 2024 will take place as an onsite event in Munich, Germany, from 26 to 29 June 2024, as well as online, through a dedicated virtual platform.
Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.
In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern.
The ESMO Gastrointestinal Cancers Congress is a place for the global GI oncology community to present and discuss impactful new research data in gastrointestinal oncology, in a comprehensive programme also rich in high-quality educational sessions. The congress offers excellent networking opportunities in an international environment.
Learning objectives
In the Keynote lectures, Educational sessions, Multidisciplinary Tumour Board sessions, Special Symposia, Scientific sessions and Poster exhibition, attendees will be able to update their knowledge on:
- To update oncology health care professionals on recent developments in state of the art management of patients with gastrointestinal malignancies
- To present latest insights in the molecular prevention, diagnosis and precision therapy of gastrointestinal cancers
- To provide in-depth expert knowledge in controversy areas in gastrointestinal oncology
Accreditation
ESMO-MORA: The ESMO Gastrointestinal Cancers 2024 Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology.
Disclaimer
All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).
The experts invited by ESMO as Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.
The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.
For further details about the congress, including registration, please click here.
Congress at a glance
Venue: ICM-International Congress Center of the Munich Messe – Messegelände, 81823 Munich, Germany
When: June 26-29, 2024
Contact